Clinical Genomics
Reviews high throughput translational genomic sequencing for diagnosis, prognosis and precision management of inherited and somatic disorders
Shashikant Kulkarni (Edited by), Somak Roy (Edited by)
9780124047488
Hardback, published 12 November 2014
488 pages
27.6 x 21.5 x 2.9 cm, 1.59 kg
"...presents key bioinformatic challenges and the solutions that must be addressed by clinical genomicists and genomic pathologists, such as specific pipelines for identification of the full range of variants that are clinically important." --Anticancer Research, February 2015
Clinical Genomics provides an overview of the various next-generation sequencing (NGS) technologies that are currently used in clinical diagnostic laboratories. It presents key bioinformatic challenges and the solutions that must be addressed by clinical genomicists and genomic pathologists, such as specific pipelines for identification of the full range of variants that are clinically important.
This book is also focused on the challenges of diagnostic interpretation of NGS results in a clinical setting. Its final sections are devoted to the emerging regulatory issues that will govern clinical use of NGS, and reimbursement paradigms that will affect the way in which laboratory professionals get paid for the testing.
Section 1: Methods
- Overview of technical aspects and chemistries of NGS: Dr Robi Mitra, Washington University School of Medicine.
- Non-selective methods (genome-wide): Dr Mark Bogoski, Harvard Medical School
- Capture based methods (exome, panels) Dr Birgit Funke, Harvard Medical School
- Amplification based methods (panels): Dr Madhuri Hegde, Emory Medical School
- Emerging technologies (Nanopore and others); impact on cost and turnaround time: Dr Elaine Mardis, Washington University School of Medicine.
Section 2: Bioinformatics
- Base calling and alignment; quality metrics; depth of coverage: Dr Carl Volkerding, University of Utah, ARUP labs
- Single nucleotide variants (SNVs): Dr David Spencer, Washington University School of Medicine
- Insertions and deletions (Indels): Drs Eric Duncavage and Haley Abel, Washington University School of Medicine
- Large structural alterations (big deletions, translocations, and so on): Dr Charles Mullighan, St Jude’s Cancer Institute
- Copy number variants (CNVs): Dr Mary-Claire King, University of Washington
Section 3: Interpretation
- Reference data bases for disease associations: Dr Heidi Rehm, Harvard Medical School
- Reporting of results; level of evidence for associations; classes of associations: Dr Shashikant Kulkarni, Washington University School of Medicine
- Constitutional diseases (with individual chapters on hypertrophic cardiomyopathy, congenital deafness, blindness, cancer syndromes, and so on): Dr David Bick and Dr David Dimmock, Medical College of Wisconsin
- Cancer (with individual chapters on leukemia, lymphoma, lung cancer, colon cancer, and so on): Dr John Pfeifer, Washington University School of Medicine
Section 4: Regulatory Issues
- Assay validation: Dr Ira Lublin, CDC and Dr Elizabeth Mansfield FDA
- QA/QC/PT issues: Dr Elaine Lyon, University of Utah, ARUP labs
- Consent and privacy issues: Dr James DuBois, Albert Gnaegi Center for Health Care Ethics
Section 5: Reimbursement
- Billing: Andrew Drury and Kris Rickoff, Washington University School of Medicine
Subject Areas: Medical genetics [MFN]
